Biotech Startup D3Bio Completes $200 Million Series A Round

Chinese biotech firm D3Bio has recently announced the completion of a US$200 million Series A financing. This round of financing is co-invested by Boyu Capital, Matrix Partners China, Sequoia China, Temasek and WuXi AppTec Venture Capital Fund. The funds raised will be used to support the company to develop its product pipeline portfolio for the […]

Biotech Startup D3Bio Completes $200 Million Series A Round comes from China Money Network: Primary Data for China’s Primary Markets!…

This news comes via ChinaPulse.com, which delivers news, data, analysis, and insights on Chinese business, travel, finance, health, military, investment, and technology.

Comments are closed.